ArticleDiabetology & metabolic syndrome2026

Real-world efficacy and safety of SGLT2 inhibitor add-on triple therapy in south indian patients with type 2 diabetes mellitus: a 24-week prospective observational cohort study.

Ananya Ginjupalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.